Oral Glutathione Supplementation in Older Healthy Adults and Its Effect on the Number of Healthy Days Experienced During Four Months of Supplementation Compared to Placebo
Completed · Not applicable · Has a placebo group
Conditions studied: Improvement in Immune Cell Function in Elderly Humans
In brief
A randomized, double blind placebo-controlled parallel intervention in adults over the age of 50 will be performed. Participants will receive a supplement capsule containing placebo (Crystalline Cellulose) or 500mg of Setria® Glutathione to eat for 120 days. Glutathione is hypothesized to replenish the body's reserves that may be depleted through natural aging process, poor diet, or due to the detoxification process for drugs. The primary end point is the number of healthy days experienced during the duration of the study. Secondary endpoints include cellular and biochemical measures from blood samples taken before and after the study.
Key facts
- Study ID
- NCT02438956
- Run by
- University of Florida
- People needed
- 124
- Starts
- 2015-10-01
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2017-10-24
Who can join
Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- generally healthy
- must have had at least one cold during the previous year
- age 50-75
- must discontinue other dietary supplement use
You may not qualify if…
- on arthritis medication
- on hypertension medication
- severe allergies
- compromised immune system
- high cholesterol, heart failure, angina, etc.
- diagnoses of diabetes or metabolic syndrome
Where it is running
- 449 Food Science and Human Nutrition Department, University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.